Inspire Medical Systems
INSP
171 hedge funds and large institutions have $1.65B invested in Inspire Medical Systems in 2019 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 57 increasing their positions, 48 reducing their positions, and 20 closing their positions.
455% more call options, than puts
Call options by funds: $30M | Put options by funds: $5.4M
85% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 20
24% more capital invested
Capital invested by funds: $1.33B → $1.65B (+$319M)
19% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 48
10% more funds holding
Funds holding: 155 → 171 (+16)
1.2% more ownership
Funds ownership: 91.24% → 92.44% (+1.2%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$23.6M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$17.6M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$14.4M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$11M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$21.4M |
| 2 |
Morgan Stanley
New York
|
-$20.7M |
| 3 |
O
OrbiMed
New York
|
-$7.97M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$6.99M |
| 5 |
BlackRock
New York
|
-$6.09M |
INSP Hedge Fund Activity: Q4 2019 in Review
171 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q4 2019, worth a combined $1.65B — up 24% from $1.33B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new INSP positions and 20 closed out — a net gain of 17 holders — while 57 added to existing stakes and 48 trimmed.
The largest buyer was Champlain Investment Partners, adding an estimated $23.6M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $21.4M sold.
- 171 institutional investors held Inspire Medical Systems (INSP) as of Q4 2019, up from 155 in Q3 2019.
- Funds reported $1.65B of Inspire Medical Systems stock for Q4 2019, up 24% quarter-over-quarter.
- 37 funds opened new Inspire Medical Systems positions in Q4 2019 and 20 closed out, a net change of +17 holders.
- The largest Inspire Medical Systems buyer in Q4 2019 was Champlain Investment Partners, an estimated $23.6M added.
- The largest Inspire Medical Systems seller in Q4 2019 was PFM Health Sciences, an estimated $21.4M sold.
Based on aggregated 13F filings for Q4 2019.